Skip to main content

Table 1 Clinical and molecular summary of CNKSR2-related neurodevelopmental and epilepsy disorder

From: CNKSR2-related neurodevelopmental and epilepsy disorder: a cohort of 13 new families and literature review indicating a predominance of loss of function pathogenic variants

Family

Age (years)

Age of seizure onset

Intellectual disability?

Maternal origin?

Varianta

Source

1

8

4y

Yc

N

c.2349T>G, p.(Tyr783*)

This study

2

21

15mb

Y

Y

c.1537C > T, p.(Pro513Ser)e

This study

3

5

2y

Yc

N

c.1988_1989del, p.(Arg663Asnfs*2)

This study

4

10

6m

Y

N

c.1653_1656del, p.(Asn551Lysfs*4)

This study

5

9

4y

N → Yd

Y

c.2545C > T, p.(Arg849*)

This study

6

8

7d

Yc

N

c.2145 + 1G > A

This study

7

9

8m

Yc

Y

arr [hg19] Xp22.12 (21,278,397–21,678,707) × 0

This study

8

7

2y

Y

N

c.1198C > T, p.(Arg400*)

This study

9

9

4d

Yc

N

c.2044 + 2 T > A

This study

10

5

2y

Yc

N

c.520-1G > A

This study

11

11

23m

Y

N

c.2005del, p.(Ala669Glnfs*48)

This study

12

3

2y

Yc

N

c.1905-2A > G

This study

13

8

2y

Yc

N

c.2026_2027del, p.(Arg676Aspfs*2)

This study

14

7

2y

Y

Y

arr [hg19] Xp22.12 (21,322,029–21,678,137) × 0

Aypar et al. [1]

15

5

2.5y

Y

Y

arr [hg19] Xp22.12 (21,375,312–21,609,484 × 0

Houge et al. [7], Vaags et al. [17] pt 3

16

6

2y

Yc

Y

arr [hg19] Xp22.12 (20,297,696–21,471,387) × 0

Vaags et al. [17] pt 1

8

27m

Yc

Y

 

Vaags et al. [17] pt 2

17

12

8d

Yc

Y

arr [hg19] Xp22.12 (21,193,947–21,707,169) × 0

Vaags et al. [17] pt 4

13

N/A

Yc

Y

 

Vaags et al. [17] pt 5

18

56

?b

Yc

Y

g.21458832_21458833ins, p.(Asp152Argfs*8)

Vaags et al. [17] pt 6, Hu et al. [8], family P180

58

?b

Yc

Y

 

Vaags et al. [17] pt 7, Hu et al. [8], family P180

62

?b

Yc

Y

 

Vaags et al. [17] pt 8, Hu et al. [8], family P180

19

18

3.5y

Yc

Y

c.2341C > T, p.(Arg712*)

Damiano et al. [5]

12

3.5y

Y

Y

 

Damiano et al. [5] brother

?

3.5yb

Y

?

 

Damiano et al. [5] maternal unclef

20

9

2y

Y

N

c.2185C > T, p.(Arg729*)

Sun et al. [15]

21

6

2y

Y

N

c.2024_2027del, p.(Glu657Glyfs*41)

Bonardi et al. [2] pt 1

22

21

3yb

N → Yd

N

c.246_247del, p.(Thr83Lysfs*30)

Bonardi et al. [2] pt 2

23

12

4y

Yc

Y (mosaic)

c.457_461del, p.(Tyr153Serfs*5)

Bonardi et al. [2] pt 3

24

10

3y

Yc

N

arr [hg19] Xp22.12 (21,609,392–21,619,786) × 0

Bonardi et al. [2] pt 5

25

5

4y

Y

Y

arr [hg19] Xp22.12 (21,606,698–21,616,207) × 0

Daoqi et al. [6]

“Younger”

3y

Y

Y

 

Daoqi et al. [6] brother

26

6

N/A

Y

Y

c.1904 + 1G > A

Zhang et al. [20]

Females

      
 

N/A

N

?

c.1537C > T, p.(Pro513Ser)

Mother in family 2

 

N/A

N

?

c.2545C > T, p.(Arg849*)

Mother in family 5

 

N/A

N

?

arr [hg19] Xp22.12 (21,278,397–21,678,707) × 1

Mother in family 7

 

N/A

N

?

arr [hg19] Xp22.12 (21,322,029–21,678,137) × 1

Mother in family 14

 

N/A

N

N

arr [hg19] Xp22.12 (21,375,312–21,609,484) × 1

Mother in family 15

 

N/A

N

?

arr [hg19] Xp22.12 (20,297,696–21,471,387) × 1

Mother in family 16

 

16

6y

Y

Y

c.2341C > T, p.(Arg712*)

Sister in family 19

?

febrile

N

N

Mother in family 19

27

7

5y

Y

N

c.2304G > A, (p.Trp768*)

Polla et al. [14]

28

41

6yb

N → Yd

?

arr [hg19] Xp22.12 (21,523,673–21,558,329) × 1

Bonardi et al. [2], Lesca et al. [9] pt 4

 

?

Junior high

Y

N

arr [hg19] Xp22.12 (21,606,698–21,616,207) × 1

Mother in family 25

 

33

N/A

?

N

c.1904 + 1G > A

Mother in family 26

  1. d Days, m months, y years, N/A not applicable, pt patient
  2. aIn this cohort, transcript NM_014927 (GRCh37p13) confirmed for families 1, 2, 4, 5, 6, 7, 8, 11, 12, 13
  3. bSeizures stopped in pre-teen years
  4. cMinimal-to-no speech
  5. dDevelopmental delay manifested after onset of seizures
  6. eClassified by laboratory as variant of uncertain significance
  7. fNot tested for familial CNKSR2 pathogenic variant, but neurological and seizure phenotype matches that seen in the proband